BioCentury
ARTICLE | Clinical News

NKTR-171: Phase I started

January 20, 2014 8:00 AM UTC

Nektar began a Phase I trial to evaluate single ascending-doses of NKTR-171 in up to 50 healthy volunteers. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article